Injection dextrose

Commonly administered LVPs include such products as Lactated Ringers Injection USP, Sodium Chloride Injection USP (0.9%), which replenish fluids and electrolytes, and Dextrose Injection USP (5%), which provides fluid plus nutrition (calories), or various combinations of dextrose and saline. In addition, numerous other nutrient and ionic solutions are available for clinical use, the most popular of which are solutions of essential amino acids or lipid emulsions. These solutions are modified to be hypertonic, isotonic, or hypotonic to aid in maintaining both fluid, nutritional, and electrolyte balance in a particular patient according to need. Indwelling needles or catheters are required in LVP administration. Care must be taken to avoid local or systemic infections or thrombophlebitis owing to faulty injection or administration technique. 

NITROGLYCERIN IN DEXTROSE INJECTION 250ML BAG 12 BAGS/PACKAGE 6505013432489 PG 58.53 ... 

Alcohol in dextrose injection Ammonium chloride injection Arginine hydrochloride injection Calcium chloride injection Calcium gluceptate injection Calcium gluconate injection Calcium levulinate injection Dextrose injection... 

Mannitol in sodium chloride injection Potassium acetate injection Potassium chloride injection Potassium chloride in dextrose injection Potassium chloride in dextrose and sodium chloride injection... 

A medication order for an intravenous infusion for a patient weighing 143 lbs calls for a 0.25 mEq of ammonium chloride per kilogram of body weight to be added to 500 mL of 5% dextrose injection. How many... 

How many milliliters of sterile water for injection must be added to a liter of a 50% w/v dextrose injection to reduce the concentration to 10%... 

IV administration - Do not exceed 1.5 mL/min of a 10% concentration (or its equivalent), except in cases of severe eclampsia with seizures. Dilute IV infusion solutions to a concentration of 20% or less prior to IV administration. The most commonly used diluents are 5% dextrose injection and 0.9% sodium chloride Injection. 

The dosage as an additive in parenteral fluid therapy is predicated on specific requirements of the patient. The appropriate volume is then withdrawn for proper dilution. Having determined the mEq of sodium chloride to be added, divide by 4 to calculate the number of mL to be used. Withdraw this volume and transfer into appropriate IV solutions, such as 5% dextrose injection. The properly diluted solution may be given IV. 

Admixture compatibility- Digoxin injection can be administered undiluted or diluted with a 4-fold or greater volume of sterile water for injection, 0.9% sodium chloride injection, or 5% dextrose injection. The use of less than 4-fold volume of diluent could lead to precipitation of the digoxin. Immediate use of the diluted product is recommended. 

Fluid load Lower concentrations of nitroglycerin IV and nitroglycerin in dextrose injection increase the potential precision of dosing, but these concentrations increase the total fluid volume that must be delivered to patients. Total fluid load may be a dominant consideration in patients with compromised function of the heart, liver, and/or kidneys. 

AII infusions should be made up to final volume with 5% dextrose injection, USP. 

Alternatively, a loading infusion containing 20 mg/mL (1 g diluted to 50 ml with 5% dextrose injection, USP) may be administered at a constant rate of 1 mL/min for 25 to 30 minutes to deliver 500 to 600 mg. Some effects may be seen after infusion of the first 100 or 200 mg it is unusual to require more than 600 mg to achieve satisfactory antiarrhythmic effects. 

To maintain therapeutic levels, a more dilute IV infusion at a concentration of 2 mg/mL is convenient (1 g in 500 mL 5% dextrose injection), and may be administered at 1 to 3 mL/min. If daily total fluid intake must be limited, a 4 mg/mL concentration (1 g in 250 mL of 5% dextrose injection) administered at 0.5 to 1.5 mL/min will deliver an equivalent 2 to 6 mg/min. Assess the amount needed in a given patient to maintain the therapeutic level principally from the clinical response. Adjust based on close observation. A maintenance infusion rate of 50 mcg/kg/min to a person with a normal renal procainamide elimination half-life of 3 hours should produce a plasma level of about 6.5 mcg/mL. 

Compatibility/Stability- Esmolol, at a final concentration of 10 mg/mL, is compatible with the following solutions and is stable for 24 hours or more at controlled room temperature or under refrigeration 5% dextrose injection 5% dextrose in Lactated Ringer s injection 5% dextrose in Ringer s injection 5% dextrose and 0.9% or 0.45% sodium chloride injection Lactated Ringer s injection potassium chloride (40 mEq/L) in 5% dextrose injection 0.9% or 0.45% sodium chloride injection. 

Injection - For the management of bronchospasm during anesthesia, dilute 1 ml (0.2 mg) of a 1 5000 solution to 10 ml with sodium chloride injection or 5% dextrose injection. Administer an initial dose of 0.01 to 0.02 mg (0.5... 

Administration - The loading dose of aminophylline can be given by very slow IV push or, more conveniently, may be infused in a small guantity (usually 100 to 200 mL) of 5% Dextrose Injection or 0.9% Sodium Chloride Injection. Do not exceed the rate of 25 mg/min. Thereafter, maintenance therapy can be administered by a large volume infusion to deliver the desired amount of drug each hour. Aminophylline is compatible with most commonly used IV solutions. Oral therapy should be substituted for intravenous aminophylline as soon as adeguate improvement is achieved. 

Seizures associated with eciampsia Initial dose is 10 to 14 g magnesium sulfate. To initiate therapy, 4 g magnesium sulfate in water for injection (premixed) or 4 to 5 g in 250 ml of 5% dextrose injection or 0.9% sodium chloride injection administered IV. Simultaneously, 4 to 5 g magnesium sulfate administered IM into each buttock using 50% magnesium sulfate injection. 

IV infusion (20 or 40 mg) over 10 to 30 minutes A solution for IV infusion is prepared by first reconstituting the contents of 1 vial with 5 ml of 0.9% sodium chloride injection, lactated Ringer s injection, or 5% dextrose injection, and further diluting the resulting solution to a final volume of 50 ml. The solution (admixture) should be administered as an IV infusion over a period of 10 to 30 minutes. 

IV administration - Administer over approximately 30 minutes. Reconstitute with 50 or 100 ml of a compatible IV fluid. Cefepime is compatible at concentrations of 1 to 40 mg/mL with 0.9% Sodium Chloride Injection, 5% and 10% Dextrose Injection, M/6 Sodium Lactate Injection, 5% Dextrose and 0.9% Sodium Chloride Injection, Lactated Ringers and 5% Dextrose Injection, Normosol-R or Normosol-M in 5% Dextrose injection. 

IM administration Reconstitute cefepime with the following diluents Sterile Water for Injection, 0.9% Sodium Chloride, 5% Dextrose Injection, 0.5% or 1 % lidocaine hydrochloride, or Sterile Bacteriostatic Water for Injection with parabens or benzyl alcohol. 

Do not add additives or other medications to IV moxifloxacin or infuse simultaneously through the same IV line. If the same IV line is used for sequential infusion of other drugs, or if the piggyback method of administration is used, flush the line before and after infusion of moxifloxacin IV with a compatible solution. Moxifloxacin IV is compatible with the following IV solutions at ratios from 1 10 to 10 1 0.9% sodium chloride injection, IM sodium chloride injection, 5% dextrose injection, sterile water for injection, 10% dextrose for injection, Lactated Ringer s for injection. 

IV administration Administer over a period of 30 to 120 minutes. Do not use IV infusion bag in series connections. Do not introduce additives into this solution. Do not administer concomitantly with another drug administer each drug separately. Compatible IV solutions 5% dextrose injection, 0.9% sodium chloride injection lactated Ringer s injection. 

IV- Dissolve the contents of 1 vial in 3 to 5 mL of Sterile Water for Injection or 5% Dextrose Injection. Further dilute the calculated dose in 50 to 250 mL of 5% Dextrose solution. 

Anesthesia of the perineum and lower extremities Intrathecal 1 ml(10mg)asa l%so-lution, diluted with equal amount of CSF or 10% dextrose injection. 

To be reconstituted in 5 mL diluent of choice from an IV bag. The following preservative-free diluents are recommended for reconstitution 5% dextrose injection (D5W), USP 0.9% sodium chloride injection, USP 5%... 

Amphotericin B IV Infusion Initially 1 mg (base) as a test dose, administered in 20 mL of 5% dextrose injection over a period of 20 to 30 minutes, with 5 mg to 10 mg incremental increases depending on patient tolerance and severity of the infection, up to a maximum of 0.5 to 0.7 mg/kg Should be infused over a period of 2 to 6 hours... 

---